Cargando…
Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report
The treatment with fondaparinux is the effective and safe anticoagulant therapy in liver transplant patient on immunosuppressive therapy with arterial thrombosis, and it seems able to reduce liver fibrosis. Although this treatment is not generalizable, further prospective large studies need to confi...
Autores principales: | Cafolla, Arturo, Gentile, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331225/ https://www.ncbi.nlm.nih.gov/pubmed/28265403 http://dx.doi.org/10.1002/ccr3.820 |
Ejemplares similares
-
The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018) -
Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
por: Shimizu, Kazuhiro, et al.
Publicado: (2016) -
Recurrent thrombosis rescued by fondaparinux in high‐risk patients: A case series
por: Tanguay, Mégane, et al.
Publicado: (2022) -
The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018) -
Anticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria
por: Dragoni, Francesco, et al.
Publicado: (2015)